Identify Patients Who May Qualify for Meds to Prevent COVID-19 After Exposure

You'll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...especially with cases on the rise.

This monoclonal antibody combo blocks the virus that causes COVID-19...SARS-CoV-2...from entering cells.

It's given as an IV infusion...or as 4 subcutaneous injections.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote